Activation-Induced Cytidine Deaminase Deficiency Causes Organ-Specific Autoimmune Disease
Author(s) -
Koji Hase,
Daisuke Takahashi,
Masashi Ebisawa,
Sayaka Kawano,
Kikuji Itoh,
Hiroshi Ohno
Publication year - 2008
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0003033
Subject(s) - activation induced (cytidine) deaminase , cytidine deaminase , autoimmune gastritis , somatic hypermutation , immunology , germinal center , biology , autoimmunity , autoimmune regulator , autoimmune disease , ciita , lymphoid hyperplasia , adoptive cell transfer , immunoglobulin class switching , b cell , effector , t cell , mhc class ii , immune system , antibody , lymphoma
Activation-induced cytidine deaminase (AID) expressed by germinal center B cells is a central regulator of somatic hypermutation (SHM) and class switch recombination (CSR). Humans with AID mutations develop not only the autosomal recessive form of hyper-IgM syndrome (HIGM2) associated with B cell hyperplasia, but also autoimmune disorders by unknown mechanisms. We report here that AID −/− mice spontaneously develop tertiary lymphoid organs (TLOs) in non-lymphoid tissues including the stomach at around 6 months of age. At a later stage, AID −/− mice develop a severe gastritis characterized by loss of gastric glands and epithelial hyperplasia. The disease development was not attenuated even under germ-free (GF) conditions. Gastric autoantigen -specific serum IgM was elevated in AID −/− mice, and the serum levels correlated with the gastritis pathological score. Adoptive transfer experiments suggest that autoimmune CD4 + T cells mediate gastritis development as terminal effector cells. These results suggest that abnormal B-cell expansion due to AID deficiency can drive B-cell autoimmunity, and in turn promote TLO formation, which ultimately leads to the propagation of organ-specific autoimmune effector CD4 + T cells. Thus, AID plays an important role in the containment of autoimmune diseases by negative regulation of autoreactive B cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom